Oxford Biomedica plc ( OTCPK:OXBDF) Q4 2024 Earnings Conference Call April 9, 2025 8:00 AM ET Frank Mathias - Chief Executive Officer Sebastien Ribault - Chief Business Officer Lucy Crabtree - Chief ...

ProBio, a global contract development and manufacturing organization (CDMO), is pleased to announce the launch of its GMP ...

The COVID-19 pandemic demonstrated that the mass production of vaccines is crucial for our healthcare system. In order to ...

CHO Plus, Inc. ( a leading developer of biopharmaceutical manufacturing technology, announces that U.S. Patent No. 12,270,055 ...

How to design and launch a successful Clinical Trial Manufacturing.

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Cell And Gene Therapy Market Size and ForecastThe global cell and gene therapy market is projected to witness significant ...

Spark Therapeutics Inc. has presented a proprietary adeno-associated viral (AAV) vector expressing an artificial miRNA targeting human α-synuclein (α-Syn) mRNA. Accumulation of misfolded and insoluble ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to ...

Gene therapy, a technique that is revolutionizing the treatment of multiple genetic conditions, including eye and muscle diseases and blood disorders, requires efficient and specific delivery of the ...

To help improve gene therapy, a multidisciplinary team has generated a comprehensive atlas that researchers can use to select ...